Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients.
about
Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.Comparative analysis of different biofactories for the production of a major diabetes autoantigen.Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65.Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
P2860
Q30854842-68B1DB0C-DC99-4DD7-A04A-B21DC966E7DFQ36363509-DB2DAE7A-2B0A-4D52-B18D-F20DF76336D6Q36778303-C19186B9-6BA8-4E50-926B-BC0264CC38EEQ37356382-A76C0424-C990-4D7A-AC3F-9382FFB14670Q37634156-61E7E810-9AF4-4F74-BF39-94ECBDA391E2Q41080988-67DD6C12-1563-405E-BD43-82E952F43546Q41994256-21B63F29-1967-4F5B-8289-00055CD69840
P2860
Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Characterization of a linear e ...... nt diabetes mellitus patients.
@ast
Characterization of a linear e ...... nt diabetes mellitus patients.
@en
type
label
Characterization of a linear e ...... nt diabetes mellitus patients.
@ast
Characterization of a linear e ...... nt diabetes mellitus patients.
@en
prefLabel
Characterization of a linear e ...... nt diabetes mellitus patients.
@ast
Characterization of a linear e ...... nt diabetes mellitus patients.
@en
P2093
P1433
P1476
Characterization of a linear e ...... nt diabetes mellitus patients.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1993.TB17698.X
P407
P577
1993-03-01T00:00:00Z